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Dear Editor,
The work entitled, "Are Hepatitis B Virus (HBV) and Celiac 
Disease (CD) Linked?" shows no conclusive results on the re-
lationship between HBV and CD (1). The researchers studied 
patients with chronic HBV2, patients who recovered from 
HBV2, and healthy patients but did not prove that they suf-
fered from CD. A diagnosis of CD is made by bowel biopsy, 
although screens that measure IgA, tissue transglutaminase 
(TG), and endomysium markers can be performed initially; 
in some cases, different forms of celiac disease are not di-
agnosed  early,  and  it  is  known  that  asymptomatic  forms 
increase (2). Serological tests have been used to screen and 
monitor therapy. The most sensitive and specific serological 
markers are endomysial (EMA) and TG IgA. IgA deficiency oc-
curs in 1 of 40 individuals with CD when this illness is sus-
pected clinically; however, if IgA deficiency is detected, up-
per intestinal endoscopy and biopsy should be considered, 
regardless of the serological test results (3). Autoimmune 
conditions, including autoimmune thyroid disease and type 
1 diabetes, have been associated with CD (4). Conversely, con-
firmed CD is unrelated to liver infections, such as hepatitis 
C (5). CD is a complex pathology that involves several path-
ways in which there are several gluten-sensitive populations 
of T lymphocytes that express a phenotypic memory and se-
crete interferon (5). We believe that the study population did 
not have confirmed CD; further, the methodology that was 
used to examine the issue was not suitable. The discussion 
included topics that were unrelated to their results. New 
statistical methods could probably have been used to verify 
associations or causalities. Also, it would have been appro-
priate to include patients with confirmed CD who were in-
fected with hepatitis B, regardless of INF-α therapy. In recent 
years, the use of statistical methods has been demonstrated 
to be a simple and inexpensive way of developing valuable 
methodological tools for screening populations and under-
standing complex diseases. Assessing the value of diagnostic 
indicators, such as symptoms and lab tests, allows one to es-
timate the sensitivity and specificity of these indicators and 
determine the presence or absence of pathology. Statistical 
methods, such as logistic and nonparametric discriminant 
analysis,  and  the  selection  of  features  by  filters  can  help 
in evaluating clinical and lab variables as the foundation 
of classification-prediction rules. These rules can aid clini-
cians in estimating the likelihood that an individual will be 
included in a disease category, avoiding the use of invasive 
methods and improving quality of life by early diagnosis of 
these particular pathologies.However, the questions that the 
authors pose are notable; if there is an actual link between 
HBV2 and CD, this can launch other studies that determine 
at-risk groups and develop prevention or therapeutic pro-
grams to improve the quality of life of these patients.
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